Centiva Capital, LP Boston Scientific Corp Call Options Transaction History

Centiva Capital, LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $1.15 Million - $1.37 Million	-20,000 Reduced 33.33%	40,000 $2.74 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $1.95 Million - $2.31 Million	40,000 Added 200.0%	60,000 $3.47 Million
Q3 2023 Nov 14, 2023	SELL	$50.19 - $54.68 $782,964 - $853,008	-15,600 Reduced 43.82%	20,000 $1.06 Million
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $1.61 Million - $1.78 Million	35,600 New	35,600 $1.78 Million

1,559

1.18B

6.78M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $141B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.